Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134,930 | 154,083 | 295,394 | 74,356 | 222,080 |
| Marketable Securities | 278,756 | 428,830 | 282,189 | 410,041 | 224,865 |
| Receivables | 68,145 | 11,237 | N/A | 3,474 | N/A |
| Inventories | 32,754 | 366 | N/A | N/A | N/A |
| TOTAL | $528,081 | $603,057 | $580,876 | $489,786 | $448,396 |
| Non-Current Assets | |||||
| PPE Net | 181 | N/A | 8 | 20 | 278 |
| Investments And Advances | 0 | 119,520 | 29,829 | 5,469 | 0 |
| Other Non-Current Assets | 1,444 | 2,239 | 2,167 | 1,961 | 983 |
| TOTAL | $1,625 | $121,759 | $32,004 | $7,450 | $1,261 |
| Total Assets | $529,706 | $724,816 | $612,880 | $497,236 | $449,657 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,580 | 42,973 | 17,193 | 4,350 | 5,669 |
| Accrued Expenses | 103,064 | 60,096 | 39,856 | 24,276 | 14,465 |
| Other current liabilities | N/A | N/A | N/A | N/A | 187 |
| TOTAL | $120,116 | $103,549 | $58,096 | $29,065 | $20,683 |
| Non-Current Liabilities | |||||
| Long Term Debt | 343,909 | 331,565 | N/A | N/A | 19,895 |
| Other Non-Current Liabilities | 1,051 | 1,578 | 578 | 709 | 711 |
| TOTAL | $344,960 | $333,143 | $588 | $722 | $20,606 |
| Total Liabilities | $465,076 | $436,692 | $58,684 | $29,787 | $41,289 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,201 | 86,024 | 84,965 | 68,443 | 55,012 |
| Common Shares | 9 | 9 | 8 | 7 | 6 |
| Retained earnings | -1,506,580 | -1,221,158 | -902,400 | -693,040 | -543,702 |
| Other shareholders' equity | 452 | 163 | 218 | -806 | 45 |
| TOTAL | $64,630 | $288,124 | $554,196 | $467,449 | $408,368 |
| Total Liabilities And Equity | $529,706 | $724,816 | $612,880 | $497,236 | $449,657 |